Xenia Dimont

Her responsibilities include conducting official inspections of manufacturers of active pharmaceutical ingredients and medicinal products according to Section 64 of the German Medicines Act (AMG) in Germany and in third countries, e.g. on behalf of the European Medicines Agency (EMA).

After studying pharmacy at the Heinrich Heine University in Düsseldorf, Ms Dimont gained professional experience in various pharmacies before joining the Government of Upper Bavaria (ROB) in Munich in 2011.

Ms Dimont's responsibilities include the supervision of manufacturers and distributors of blood products in accordance with Section 64 of the German Medicines Act (AMG). Since 2020, she has been head of the Blood Division in the Pharmacy Department of the Government of Upper Bavaria and is a member of the official State Committee Expert Group 06 "Blood/Blood Products".

Since 2020, Ms Dimont has also been active as a speaker on GMP and GDP topics at various training events and conferences and has recently been working as an author for PharmInd on the topic of sterile technology.